Literature DB >> 7010177

Rise of plasma aldosterone during long-term captopril treatment.

J Staessen, P Lijnen, R Fagard, L J Verschueren, A Amery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7010177     DOI： 10.1056/nejm198104303041819

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Global cardiovascular protection in chronic kidney disease.

Authors:  Gema Ruiz-Hurtado; Pantelis Sarafidis; María S Fernández-Alfonso; Bernard Waeber; Luis M Ruilope
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

2.  Captopril in children with dilated cardiomyopathy: acute and long-term effects in a prospective study of hemodynamic and hormonal effects.

Authors:  H Stern; J Weil; T Genz; W Vogt; K Bühlmeyer
Journal:  Pediatr Cardiol       Date:  1990-01       Impact factor: 1.655

Review 3.  Role of aldosterone in the progression of chronic kidney disease and potential use of aldosterone blockade in children.

Authors:  Elaine Ku; Vito M Campese
Journal:  Pediatr Nephrol       Date:  2009-04-04       Impact factor: 3.714

4.  Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.

Authors:  R A Sánchez; E Marcó; H B Gilbert; P Raffaele; M Brito; M Giménez; L I Moledo
Journal:  Drugs       Date:  1985       Impact factor: 9.546

5.  Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease.

Authors:  E Ritz; B Pitt
Journal:  Clin Kidney J       Date:  2013-09-01

6.  The neuropeptide substance P regulates aldosterone secretion in human adrenals.

Authors:  Julien Wils; Céline Duparc; Estelle Louiset; Hervé Lefebvre; Anne-Françoise Cailleux; Antoine-Guy Lopez; Caroline Guiheneuf; Isabelle Boutelet; Hadrien-Gaël Boyer; Christophe Dubessy; Saloua Cherifi; Bruno Cauliez; Françoise Gobet; Guillaume Defortescu; Jean-François Ménard
Journal:  Nat Commun       Date:  2020-05-29       Impact factor: 14.919
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.